Results from this study thus identified putative targets that are co-expressed with HER2 in colorectal cancer, which are different from HER2 in breast cancer, warranting further investigation into their role in colorectal cancer pathogenesis. This evidence concerns the gene ERBB2 and colorectal cancer.